雜志介紹

Molecular Psychiatry雜志介紹

《Molecular Psychiatry》是一本以English為主的未開放獲取國(guó)際優(yōu)秀期刊，中文名稱分子精神病學(xué)，本刊主要出版、報(bào)道醫(yī)學(xué)-BIOCHEMISTRY & MOLECULAR BIOLOGY領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用，也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為9.6，最新CiteScore 指數(shù)為20.5。

本刊近期中國(guó)學(xué)者發(fā)表的論文主要有：

• Loss of TDP-43 function underlies hippocampal and cortical synaptic deficits in TDP-43 proteinopathies

  Author: Ni, Jiangxia; Ren, Yongfei; Su, Tonghui; Zhou, Jia; Fu, Chaoying; Lu, Yi; Li, De'an; Zhao, Jing; Li, Yunxia; Zhang, Yaoyang; Fang, Yanshan; Liu, Nan; Geng, Yang; Chen, Yelin

• A systematic review and meta-analysis of long term physical and mental sequelae of COVID-19 pandemic: call for research priority and action

  Author: Zeng, Na; Zhao, Yi-Miao; Yan, Wei; Li, Chao; Lu, Qing-Dong; Liu, Lin; Ni, Shu-Yu; Mei, Huan; Yuan, Kai; Shi, Le; Li, Peng; Fan, Teng-Teng; Yuan, Jun-Liang; Vitiello, Michael V.; Kosten, Thomas; Kondratiuk, Alexandra L.; Sun, Hong-Qiang; Tang, Xiang-Dong; Liu, Mei-Yan; Lalvani, Ajit; Shi, Jie; Bao, Yan-Ping; Lu, Lin

• Environmental neuroscience linking exposome to brain structure and function underlying cognition and behavior

  Author: Liu, Feng; Xu, Jiayuan; Guo, Lining; Qin, Wen; Liang, Meng; Schumann, Gunter; Yu, Chunshui

• D1 receptor-expressing neurons in ventral tegmental area alleviate mouse anxiety-like behaviors via glutamatergic projection to lateral septum

  Author: Tong, Qiuping; Cui, Xiao; Xu, Hao; Zhang, Xiaoshuang; Hu, Songhui; Huang, Fang; Xiao, Lei

英文介紹

Molecular Psychiatry雜志英文介紹

Molecular Psychiatry publishes papers elucidating the biological mechanisms underlying psychiatric disorders and their treatment. The emphasis is on studies at the interface of pre-clinical and clinical research, including studies at the cellular, molecular, integrative, clinical, imaging and psychopharmacology levels.